INTERNATIONAL PATENT: EPOK THERAPEUTICS INC. FILES APPLICATION FOR "TETRAVALENT AGONISTS OF ERYTHROPOIETIN RECEPTOR"

GENEVA, Nov. 24 -- EPOK THERAPEUTICS INC. (333 Bay Street / Suite 2400Toronto, Ontario M5H 2T6) filed a patent application (PCT/IB2025/054978) for "TETRAVALENT AGONISTS OF ERYTHROPOIETIN RECEPTOR" on May 13, 2025. With publication no. WO/2025/238528, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BLAZER, Levi L. (c/o EPOK THERAPEUTICS INC., 333 Bay Street, Suite 2400Toronto, Ontario M5H 2T6), ADAMS, Jarrett (c/o EPOK THERAPEUTICS INC., 333 Bay Street, Suite 2400Toronto, Ontario M5H 2T6), MOE, Orson W. (c/o EPOK THERAPEUT...